Forum on immune digital twins

Jahr

2023

Autoren

Laubenbacher RC, Adler F, An G, Castiglione F, Eubank S, Fonseca LL, Glazier JA, Helikar T, Jett-Tilton M, Kirschner D, Macklin P, Mehrad B, Moore B, Pasour VB, Shmulevich I, Smith A, Voigt I, Yankeelov TE, Ziemssen T.

Verlag

arXiv:2310.18374.

Link

https://doi.org/10.48550/arXiv.2310.18374

Forum on immune digital twins

Patients with relapsing-remitting multiple sclerosis show accelerated whole brain volume and thalamic volume loss early in disease

Challenges and implications of anti-JCV antibody serology variability among different assays in natalizumab treatment: A call for standardization and transparency in clinical practice

MS brain health quality standards: a survey on the reality in clinical practice in Germany

Best supportive care for patients with primary progressive multiple sclerosis (PPMS) in Germany prior to ocrelizumab treatment: Final results from the RETRO PPMS study

Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study